Covovax

NEW DELHI The Serum Institute of India will try to launch Omicron-specific vaccine for Covid-19 after six months, its CEO Adar Poonawalla said on Thursday. Speaking to reporters on the sidelines of an event, he said there is good data…

The Drugs Controller General of India (DCGI) on Tuesday approved Serum Institute's COVID-19 vaccine Covovax for restricted emergency use in children aged 7 to 11 years subject to certain conditions, official sources said. The DCGI's nod…

The Drugs Controller General of India (DCGI) on Tuesday approved India’s first indigenously developed mRNA vaccine against COVID-19 manufactured by Gennova Biopharmaceuticals for restricted emergency use for those aged 18 years and…

An expert panel of India's central drug authority on Friday recommended granting emergency use authorisation to Serum Institute's Covovax for children aged 7 to 11 years, official sources said. The recommendation has been sent to Drugs…

The subject expert committee on COVID-19 of India's drug regulator will on Friday review the applications of Serum Institute of India seeking emergency use authorisation to use Covovax among those aged two to seven years and seven to 11…